VIENNA — An algorithm, the Steatosis-Associated Fibrosis Estimator (SAFE), was developed to detect clinically significant fibrosis in patients with nonalcoholic fatty liver disease (NAFLD).

Changing NAFLD and/or changing its definition will ... We are improving our diagnostic algorithms and we are beginning to have FDA-approved drugs. It will be worrisome if we change the disease ...

Individuals with diabetes and hypertension are especially at risk and should undergo screening for NAFLD (Non-Alcoholic Fatty ...

we provide a practical management and treatment algorithm for clinicians in how to approach ruling out alternative causes of increased liver fat in lean persons with suspected NAFLD. Other ...

NASH occurs when a “fatty liver” or nonalcoholic fatty liver disease (NAFLD) leads to inflammation and liver cell damage called fibrosis. In its most severe form, it can be fatal.

The rates of nonalcoholic fatty liver disease — which can lead to life-threatening conditions, including cirrhosis and cancer of the organ — have been soaring over the past three decades ...

Study reveals that a flavonoid-rich diet, especially with apples and tea, may reduce liver fat and inflammation, lowering the risk of NAFLD. Study: A Flavonoid-Rich Diet is Associated with Lower ...